Press Releases - 2023-12-08

Date	Title	Company
08-Dec-2023	MEDFINITI Introduces HemWell MD: Along with its Breakthrough in Hemorrhoid Technology "HemWell"	AccessWire
08-Dec-2023	Ribometrix Demonstrates Rapid Progress for eIF4E Program at San Antonio Breast Cancer Symposium	Businesswire
08-Dec-2023	Vertex and CRISPR Therapeutics Announce US FDA Approval of CASGEVY™ (exagamglogene autotemcel) for the Treatment of Sickle Cell Disease	Businesswire
08-Dec-2023	Genentech’s Kadcyla Is the First Targeted Therapy to Show Significant Overall Survival Benefit in People With HER2-Positive Early-Stage Breast Cancer With Residual Invasive Disease After Neoadjuvant Treatment	Businesswire
08-Dec-2023	Genentech’s Inavolisib Combination Reduces the Risk of Disease Progression by 57% in People With Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer With a PIK3CA Mutation	Businesswire
08-Dec-2023	Biosurgery Market Analysis: Innovations, Trends, and Growth Trajectories \| CAGR 9.1%	The Wire Times
08-Dec-2023	Cell Analysis Market: Unraveling Innovations and Growth Trajectories \| CAGR 9.5%	The Wire Times
08-Dec-2023	GE HealthCare Announces Cash Dividend for Fourth Quarter of 2023	Businesswire
08-Dec-2023	Cosmos Health to Participate at Capital Link’s 'Invest in Greece' Forum in New York	AccessWire
08-Dec-2023	Revive Recovery and Detox Services Clarifies NO AFFILIATION With Revive Premier Treatment Center	AccessWire
08-Dec-2023	Veradigm Inc. Announces Leadership Transition	Businesswire
08-Dec-2023	STORM Therapeutics’ First-in-Class tRNA methyltransferase inhibitor of METTL1 to be Presented at the 65th Annual ASH Conference	STORM Therapeutics
08-Dec-2023	Defibrillators Market to Witness Outstanding Growth of USD 24.60 Billion by 2030 \| Annual Growth	The Wire Times
08-Dec-2023	Latest Novartis Kisqali® NATALEE analysis reinforces 25% reduction in risk of recurrence across broad population of patients with early breast cancer; supports regulatory submissions	Novartis
08-Dec-2023	ABL DIAGNOSTICS EXPANDS ITS HIV GENOTYPING ASSAYS OFFERING	ABL DIAGNOSTICS
08-Dec-2023	Lynparza (olaparib) in combination with bevacizumab receives positive final recommendation from NICE for first-line treatment of advanced (stage IIIB-IV) HRD-positive ovarian cancer	AstraZeneca
08-Dec-2023	ACG Inspection launches new cloud-based offering to address upcoming VRS requirements under DSCSA regulations.	ACG Inspection
08-Dec-2023	Menarini Group Presents New Progression-Free Survival Data from EMERALD Clinical Study of ORSERDU® (Elacestrant) in Clinically Relevant Subgroups of Patients with ER+, HER2- Metastatic Breast Cancer (mBC) with ESR1 Mutations at SABCS 2023	Businesswire
08-Dec-2023	Update on Reverse Acquisition - PMD Completes Private Placement and Major Shareholder Receives Exemption from Mandatory Bid Requirements	AccessWire
08-Dec-2023	Analgesics Market Rising Range of Applications Propelling Industry at A CAGR of 8.0% 6.6% by 2030	The Wire Times